ECHINACEA

Dosage form: tablet, orally disintegrating
Ingredients: ECHINACEA ANGUSTIFOLIA 1[hp_X], HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK 2[hp_X], TRIBASIC CALCIUM PHOSPHATE 3[hp_X], GOLDENSEAL 4[hp_X], POLYGALA SENEGA ROOT 4[hp_X], SILICON DIOXIDE 4[hp_X], CONIUM MACULATUM FLOWERING TOP 4[hp_X], SODIUM TETRACHLOROAURATE 5[hp_X], OYSTER SHELL CALCIUM CARBONATE, CRUDE 5[hp_X], FUCUS VESICULOSUS 5[hp_X], LACHESIS MUTA VENOM 8[hp_X]
Labeler: Marco Pharma International LLC.
NDC Code: 60986-2000

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Facts

Active Ingredients

ECHINACEA ANGUSTIFOLIA 1XHPUS

HAMAMELIS VIRGINIANA 2XHPUS

CALCAREA PHOSPHORICA 3XHPUS

HYDRASTIS CANADENSIS 4XHPUS

SENEGA OFFICINALIS 4XHPUS

SILICEA 4XHPUS

CONIUM 4XHPUS

AURUM MURIATICUM NATRONATUM 5XHPUS

CALCAREA CARBONICA 5XHPUS

FUCUS VESICULOSUS 5XHPUS

LACHESIS MUTUS 8XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

FOR TEMPORARY RELIEF OF SORE THROATS AND LYMPHATIC INFLAMMATION.

Keep out of reach of children.

Suggested useError

Warnings

If pregnant or breast-feeding, consult a health professional before use.

(Read Suggested Use Section)

Inactive Ingredients

Faex Med. and Lactose


MM1

ECHINACEA 
echinacea angustifolia, hamammelis virginiana, calcarea phosphorica, hydrastis canadanesis, senega officinalis, silicea, conium, aurum muriaticum natronatum, calcarea carbonica, fucus vesiculosus, lachesis mutus tablet, orally disintegrating
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:60986-2000
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ECHINACEA ANGUSTIFOLIA (ECHINACEA ANGUSTIFOLIA) ECHINACEA ANGUSTIFOLIA1 [hp_X]
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK) HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK2 [hp_X]
TRIBASIC CALCIUM PHOSPHATE (CALCIUM CATION) TRIBASIC CALCIUM PHOSPHATE3 [hp_X]
GOLDENSEAL (GOLDENSEAL) GOLDENSEAL4 [hp_X]
POLYGALA SENEGA ROOT (POLYGALA SENEGA ROOT) POLYGALA SENEGA ROOT4 [hp_X]
SILICON DIOXIDE (SILICON DIOXIDE) SILICON DIOXIDE4 [hp_X]
CONIUM MACULATUM FLOWERING TOP (CONIUM MACULATUM FLOWERING TOP) CONIUM MACULATUM FLOWERING TOP4 [hp_X]
SODIUM TETRACHLOROAURATE (SODIUM CATION) SODIUM TETRACHLOROAURATE5 [hp_X]
OYSTER SHELL CALCIUM CARBONATE, CRUDE (OYSTER SHELL CALCIUM CARBONATE, CRUDE) OYSTER SHELL CALCIUM CARBONATE, CRUDE5 [hp_X]
FUCUS VESICULOSUS (FUCUS VESICULOSUS) FUCUS VESICULOSUS5 [hp_X]
LACHESIS MUTA VENOM (LACHESIS MUTA VENOM) LACHESIS MUTA VENOM8 [hp_X]
Inactive Ingredients
Ingredient NameStrength
SACCHAROMYCES CEREVISIAE 
LACTOSE 
Product Characteristics
Colorwhite (LIGHT BROWN) Scoreno score
ShapeCAPSULE (ROUND TABLET) Size12mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:60986-2000-2100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic03/01/1992
Labeler - Marco Pharma International LLC. (161994277)
Establishment
NameAddressID/FEIOperations
Nestmann Pharma GmbH323426262manufacture

Revised: 12/2011
 
Marco Pharma International LLC.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)